NYSE:GMEDMedical Equipment
Is Reaffirmed 2026 Guidance and Capital Allocation Shifting the Investment Case for Globus Medical (GMED)?
In the first quarter of 2026, Globus Medical reported sales of US$759.85 million and net income of US$124.3 million, with both basic and diluted earnings per share from continuing operations rising year-on-year, while reaffirming full-year 2026 revenue guidance of US$3.18–3.22 billion.
Management also reiterated a capital allocation plan that balances internal R&D, manufacturing expansion, share repurchases, and selective M&A, underscoring its focus on long-term profitable growth even as it...